Home Authors Posts by Jay W. Belle Isle
Jay W. Belle Isle
Last week, Johnson & Johnson (J&J) and Bayer AG had the first loss in the many Xarelto bleeding risk lawsuits. The Big Pharma duo has so far won the first three federal court cases. The Philadelphia state court jury handed down a $27.8M verdict for the plaintiffs, finding the companies didn’t adequately warn doctors and patients of the increased risk of internal bleeding with Xarelto use. The damages award is broken down into $1.8M in compensatory damages and $26M in punitive damages. The companies are already planning an appeal.
Oh, hypocrisy… how I love you! Republican state representative Wes Goodman (87th District – OH), was elected last year after serving as aide to Jim Jordan, a very conservative, anti-LGBTQ Republican. Goodman, 33, didn’t last long in his position, though. The man people called the “conscience of the conservative movement” resigned recently over “inappropriate conduct.”
Our friends at ClassAction.com recently published an excellent piece on the “profits before patients” paradigm and its impact on the opioid crisis in America, explaining steps Big Pharma takes to make mega-profits from unsuspecting patients. They have kindly offered to share an excerpt for our readers. A link to the complete article on their site appears at the end of this piece.
Our friends at Lex Machina have done it again. The creators of the award-winning Legal Analytics® platform have added a new module – federal product liability litigation. This is an exciting step forward for those involved in this complex area of law.
The latest development in the multidistrict litigation (MDL) over Ethicon’s Physiomesh for hernia treatment involves the parties squaring off over who – if anyone – is allowed to have ex parte contact with the plaintiffs’ treating physicians. What, exactly, is ex parte contact and why are the parties fighting over it?
In early October, a Chicago federal jury reached a verdict in favor of Mr. Jeffrey Konrad in his suit against Big Pharma giant AbbVie, agreeing with Mr. Konrad’s allegations that the company’s testosterone replacement drug, AndroGel, caused his heart attack. The jury gave Mr. Konrad $140,000.00 in compensatory damages and $140M in punitive damages. AbbVie promised to appeal, and it made good on that promise just a few days ago.
Residents of Dickinson, Texas recently got a bit of an unpleasant surprise in the form of a bizarre clause in the city’s Hurricane Harvey Repair Grant Application and Agreement.
The latest happenings in the ongoing talc-ovarian cancer suits against Johnson & Johnson aren’t good news, particularly for two plaintiffs whose cases were already decided. The corporation recently succeeded in its efforts to have two of the larger verdicts (one of which is the largest verdict) reversed.
You pay your premiums faithfully, are never late, and bought into the promises made by your home insurer that you would be protected in the event of an emergency. Along comes a hurricane of epic proportions – Harvey had 130mph sustained winds, an enormous storm surge, and dropped several feet of rain in a relatively short period – and you lose everything. “But,” you think, “at least I’m insured. Everything will be fine.” Sadly, that’s not proving to be the case for many people. Delayed insurance claims are the new storm slamming Texans.
Lex Machina’s Legal Analytics® platform now includes District Court Bankruptcy Appeals. Lex Machina, a LexisNexis company, unveiled the latest expansion of its award-winning platform earlier this week. That announcement, and an explanation of the benefits of this expansion, are reproduced below, courtesy of the company.